These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4708027)
1. Thalassaemia in Australia. Turner E Aust Paediatr J; 1973 Feb; 9(1):3-4. PubMed ID: 4708027 [No Abstract] [Full Text] [Related]
2. The incidence of hepatitis-associated antigen and antibody in patients with thalassaemia in Greece. Economidou J; Constantoulakis M; Augustaki O; Taylor PE; Zuckerman AJ; Baines PM; Bryceson MA Vox Sang; 1970; 19(3):401-3. PubMed ID: 4993791 [No Abstract] [Full Text] [Related]
3. The effect of the beta thalassaemia trait on pregnancy with particular reference to its complications and outcome. Hocking IW; Ibbotson RN Med J Aust; 1966 Aug; 2(9):397-400. PubMed ID: 5917156 [No Abstract] [Full Text] [Related]
4. Prevention of thalassemia in the Ferrara area. Vullo C; Lucci M; Salsini G; Toffoli C; Ravani A; Dolcini B; Venturoli A; Bardi A; Conigli P Haematologica; 1990; 75 Suppl 5():142-52. PubMed ID: 2086374 [No Abstract] [Full Text] [Related]
6. Present status of treatment of thalassemia in Greece. Loukopoulos D Birth Defects Orig Artic Ser; 1976; 12(8):1-11. PubMed ID: 795475 [No Abstract] [Full Text] [Related]
7. [Blood transfusion therapy in thalassemia major. Experience of a 5-year period of activity in the Center for Hemoglobinopathies of the Pediatric Clinic of Naples]. Esposito L; Ferrara M; Ponte G Pediatria (Napoli); 1978 Dec; 86(4):537-46. PubMed ID: 750970 [No Abstract] [Full Text] [Related]
8. Incidence of homozygous beta-thalassaemia in New South Wales, 1961-1976. Cowan J; Kerr C Med J Aust; 1982 Jun; 1(13):554-6. PubMed ID: 7110007 [TBL] [Abstract][Full Text] [Related]
9. Thalassaemia in Cyprus. Bate CM Proc R Soc Med; 1975 Aug; 68(8):514-6. PubMed ID: 1202489 [No Abstract] [Full Text] [Related]
10. Echocardiographic abnormalities in thalassaemia major with multiple transfusions. Ee B; Tan SH; Yip WC; Tay JS; Chia BL; Wong HB J Singapore Paediatr Soc; 1981; 23(1-2):68-70. PubMed ID: 7343780 [No Abstract] [Full Text] [Related]
11. [The Milan experience in screening for hemoglobinopathies]. Morganti G; Gualandri V; Orsini GB Minerva Med; 1981 Mar; 72(11):696-700. PubMed ID: 7243016 [No Abstract] [Full Text] [Related]
15. Thalassaemia in Australia. Some misconceptions. Cauchi MN Med J Aust; 1983 Aug; 2(3):110-1. PubMed ID: 6877132 [No Abstract] [Full Text] [Related]
16. Management of thalassaemia major. Modell B; Petrou M Arch Dis Child; 1983 Dec; 58(12):1026-30. PubMed ID: 6660889 [No Abstract] [Full Text] [Related]
17. The treatment of beta-thalassemia: organization. Masera G Birth Defects Orig Artic Ser; 1982; 18(7):325-8. PubMed ID: 7159741 [No Abstract] [Full Text] [Related]
18. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme. Rebulla P; Modell B Lancet; 1991 Feb; 337(8736):277-80. PubMed ID: 1671122 [TBL] [Abstract][Full Text] [Related]
19. Outcome and management of pregnancy in women with thalassaemia in Cyprus. Toumba M; Kanaris C; Simamonian K; Skordis N East Mediterr Health J; 2008; 14(3):628-35. PubMed ID: 18720627 [TBL] [Abstract][Full Text] [Related]
20. The spectrum of parathyroid function in thalassaemia subjects with transfusional iron overload. Brezis M; Shalev O; Leibel B; Dagan I; Ben-Ishay D Miner Electrolyte Metab; 1982 Dec; 8(6):307-13. PubMed ID: 6300636 [No Abstract] [Full Text] [Related] [Next] [New Search]